NCT00238654View on ClinicalTrials.gov

A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Multiple Sclerosis
All Listed Sponsors
lead

Teva Neuroscience, Inc.

INDUSTRY

NCT00238654 - A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy | Biotech Hunter | Biotech Hunter